Medibio Limited announced Mr. David Trimboli to its Board of Directors as Non-Executive Director with immediate effect. Mr. Trimboli is an experienced global investor with experience in commodities financing and trading. He has undertaken investments activities and hold diverse interests in commodities, industrial minerals, real estate and technology and mental health in Australia and internationally.

Mr. Trimboli is the founder of Seefeld Investments with offices in London, Zug and Perth. He has formerly a long serving senior coal trader at the world's large commodities trading group, Glencore International AG and was a key member of the Glencore team when the group successfully completed its IPO in London and Hong Kong. He currently holds a Managing Director position in Seefeld Investments Pty Ltd, Non-Executive Chairman in Audeara Limited and Non-Executive Director positions in the following Companies Quantum Graphite Limited, TradeMutt, Yumm Confectionar, The Reading Switch, Carecircle and Greater Outcomes, all being companies in revenue generating businesses with developed management teams and on pathways to profitability.

The Board is excited to have Mr. Trimboli join the Board who brings extensive experience to the Company, not only in the mental health space but the ASX Listing space.